pubmed-article:3875651 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0229664 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0108779 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C1516670 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C0181586 | lld:lifeskim |
pubmed-article:3875651 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:3875651 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3875651 | pubmed:dateCreated | 1985-10-16 | lld:pubmed |
pubmed-article:3875651 | pubmed:abstractText | Monoclonal antibodies directed against CD3, a T cell-specific surface molecule essentially required for activation of these cells, are highly mitogenic for resting human peripheral blood T lymphocytes. A predetermined optimal concentration of anti-CD3 monoclonal antibody WT32 was employed to activate T cells cultured in limiting-dilution microcultures containing irradiated feeder cells and exogeneous interleukin 2. Frequencies of cells triggered into clonal expansion by WT32 under these culture conditions were 0.57 to 0.72 and 0.90 to 1.10 in peripheral blood mononuclear cells and E rosette-positive cells, respectively. It appeared that WT32 could induce virtually every human peripheral blood T lymphocyte to expand into a clonal progeny of 5 to 40 X 10(4) cells in 14 to 18 days of culture. This progeny was tested for cytolytic effector function with 51Cr-labeled murine P815 targets in the presence of PHA to detect all cytotoxic T lymphocytes (CTL) regardless of specificity, and was also assayed for natural killer like activity against K562 target cells. Frequencies of cells in the human peripheral blood T cell compartment giving rise to a clonal progeny expressing CTL function was 1/3, whereas 1/6 to 1/5 expanded into effector cell populations possessing NK activity. Frequency analysis of CD4-positive and CD8-positive populations, activated by WT32 in limiting dilution microcultures, demonstrated that 1 to 6% of the CD4-positive and 100% of the CD8-positive peripheral blood T lymphocytes expanded into CTL. | lld:pubmed |
pubmed-article:3875651 | pubmed:language | eng | lld:pubmed |
pubmed-article:3875651 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3875651 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:3875651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3875651 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3875651 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3875651 | pubmed:month | Oct | lld:pubmed |
pubmed-article:3875651 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:3875651 | pubmed:author | pubmed-author:BuurmanW AWA | lld:pubmed |
pubmed-article:3875651 | pubmed:author | pubmed-author:RausJ CJC | lld:pubmed |
pubmed-article:3875651 | pubmed:author | pubmed-author:WeberW EWE | lld:pubmed |
pubmed-article:3875651 | pubmed:author | pubmed-author:VandermeerenM... | lld:pubmed |
pubmed-article:3875651 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3875651 | pubmed:volume | 135 | lld:pubmed |
pubmed-article:3875651 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3875651 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3875651 | pubmed:pagination | 2337-42 | lld:pubmed |
pubmed-article:3875651 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:meshHeading | pubmed-meshheading:3875651-... | lld:pubmed |
pubmed-article:3875651 | pubmed:year | 1985 | lld:pubmed |
pubmed-article:3875651 | pubmed:articleTitle | Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells. | lld:pubmed |
pubmed-article:3875651 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3875651 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3875651 | lld:pubmed |